Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy

European Journal of Pharmacology
P MarescaE Manni

Abstract

Propionyl-L-carnitine has been shown to exert a beneficial effect on cardiac function in different experimental models of cardiomyopathy in the rat, most likely by improving cardiac metabolism and energy production. We have previously shown that, in a strain of hamsters with hereditary dilated cardiomyopathy (BIO TO.2), the mechanical activity of papillary muscle (length-tension, velocity of shortening, shortening, work and power relationship) is significantly depressed when compared to the same parameter in normal hamsters (BIO F1.B). The repeated oral treatment with propionyl-L-carnitine (60 mg/kg per os for 7 weeks) to BIO TO.2 hamsters had a significant positive inotropic effect, as indicated by an increase in developed tension up to the levels observed in papillary muscles from normal hamsters. This action is most likely associated with metabolic effects similar to those observed in rats.

References

Jun 8, 1989·Biochimica Et Biophysica Acta·Z el Alaoui-Talibi, J Moravec
Jun 24, 1989·Molecular and Cellular Biochemistry·F Di LisaN Siliprandi
Sep 1, 1971·Journal of Molecular and Cellular Cardiology·M Fedelesova, N S Dhalla
Mar 1, 1970·Journal of Molecular and Cellular Cardiology·A LochnerJ J Van der Walt
Mar 1, 1983·Archives of Biochemistry and Biophysics·C M YorkP R Borum
Jun 1, 1993·Cardiovascular Drugs and Therapy·Z el Alaoui-TalibiJ Moravec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.